biocheck inc 品牌介绍
品牌简介
生物检验公司位于旧金山湾地区，于1997年4月成立，为全球生物医学、制药和科研市场开发和生产高质量的酶免疫分析试剂盒。创始人们带来了40多年的经验，使BioCheck能够快速向客户提供可靠而敏感的产品。 BioCheck, located in the San Francisco Bay Area, was founded in April 1997, to develop and manufacture high-quality enzyme immunoassay test kits for the worldwide biomedical, pharmaceutical and scientific research markets. The founders have brought over four decades of experience, enabling BioCheck to quickly provide reliable and sensitive products to its customers. Every BioCheck EIA kit is manufactured according to U.S. Food and Drug Administration (FDA) Good Manufacturing Practice and ISO standards in our 20,000 square foot facility in South San Francisco, California. At the present time, the company manufactures over 40 EIA test kits, of which 17 have been FDA cleared. And the test kits are distributed across the globe. BioCheck is also a leading developer of immunodiagnostics with extensive experience bringing new IVD products to market, now including development for ultra-sensitive Simoa TM assays (single molecule array) and diagnostic test kits on MS-Fast chemiluminescent platform. BioCheck is currently commercializing the MS-FAST analyzer (automated chemiluminescent immunoassay system) and associated COVID-19 test kits to allow convenient, instant, and accurate diagnosis of the disease with a bench top instrument. ANTIBODIES, CONJUGATES, AND OTHER REAGENTS ENZYME IMMUNOASSAY (EIA) KITS RESEARCH REAGENTS http://www.biocheckinc.com
每个生物检验EIA试剂盒是根据美国食品和药物管理局（FDA）良好的生产实践和ISO标准制造的，我们在加利福尼亚南圣弗朗西斯科的20000平方英尺的工厂。目前，该公司生产了40多种EIA检测试剂盒，其中17种已通过FDA认证。检测试剂盒遍布全球。
BioCheck还是一家领先的免疫诊断开发公司，拥有将新的IVD产品推向市场的丰富经验，目前包括在MS Fast化学发光平台上开发超灵敏Simoa TM分析（单分子阵列）和诊断测试试剂盒。2019冠状病毒疾病检测系统（MealChChice）目前正在商业化MS-FAST分析仪（自动化学发光免疫分析系统）和相关的COVID-19测试试剂盒，以方便、快速、准确地诊断该疾病。
联系我们
